...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Pfizer's plans for research: sounds like RVX!

"Get Zenith Epigenetics sold out (maybe to Pfizer?), leave some cash in Zenith Capital (and dividend out 90+%), which can then be used to keep RVX alive. "

This would require Zenith's shareholder's approval. Not realistic IMO.

 

Koo

Share
New Message
Please login to post a reply